Ergothioneine, CAS No. 497-30-3, is a naturally occurring amino acid derivative with unique antioxidant properties. Discovered over a century ago in ergot fungus, ET is now recognized as a "longevity vitamin" due to its potential to combat oxidative stress—a major driver of aging and chronic diseases. Unlike other antioxidants, ET is avidly retained in the body thanks to a specialized transporter called SLC22A4, which ensures it accumulates in tissues that need it most, such as the brain, liver, and red blood cells.
Potent Antioxidant: ET scavenges harmful free radicals, including hydroxyl radicals and peroxynitrite, more effectively than many other antioxidants.
Cellular Protector: It helps shield DNA, proteins, and mitochondria from oxidative damage.
Anti-Inflammatory: ET may reduce inflammation linked to diseases like Alzheimer’s, diabetes, and heart disease.
Age-Related Decline: Blood levels of ET drop after age 60, and low levels are associated with faster cognitive decline and higher mortality risk.
Since humans cannot produce ET, dietary intake is crucial. The highest concentrations are found in fungi and certain fermented foods, with mushrooms being the standout source. Here’s a breakdown of ET-rich foods:
1. Mushrooms: The Powerhouse of ET
Oyster mushrooms: Among the richest sources (up to 10,000 mg/kg dry weight in golden oyster varieties).
Shiitake: Contains ~350–2,000 mg/kg, depending on cultivation methods.
Porcini, maitake, and king oyster mushrooms: Also high in ET.
White button mushrooms: A more common but still valuable source (~150–700 mg/kg).
Fun fact: Mushrooms grown in nutrient-rich substrates (like grape marc or olive by-products) have even higher ET levels!
2. Fermented Foods
Tempeh: A fermented soybean product (~200 mg/kg).
Fermented rice bran: Contains up to 176 mg/kg.
Certain cheeses and beers: Trace amounts, but less significant.
3. Other Sources
Asparagus: Varies widely (10–160 mg/kg), likely due to soil fungi symbiosis.
Black beans, oat bran, and garlic: Moderate amounts.
Animal liver and kidney: Small quantities, but not a primary source.
Tip: Cooking methods matter! Steaming or sautéing mushrooms preserves ET better than boiling or high-heat frying.
If you're taking ET supplements (available as capsules or powders), timing can optimize absorption and benefits:
1. With or Without Food?
On an empty stomach: May enhance absorption since ET is water-soluble and less likely to compete with other nutrients. Ideal for pure ET supplements.
With meals: Better for sensitive stomachs or if the supplement contains fat-soluble ingredients (like vitamin D). Food can also slow digestion, prolonging ET’s action.
2. Morning vs. Night
Morning: May synergize with daytime energy metabolism and antioxidant needs.
Night: Some prefer taking antioxidants in the evening to combat oxidative stress accumulated during the day, though evidence is limited.
3. Synergy with Other Nutrients
Vitamin C or glutathione: Space them 2 hours apart to avoid absorption competition.
Medications: Avoid taking ET with antibiotics or antacids; wait 1–2 hours.
Practical advice: Consistency matters more than timing. Choose a routine that fits your schedule—like with breakfast or lunch—to ensure daily intake.
Research is exploding around ET's potential:
Neuroprotective Mechanisms and Therapeutic Applications
Elucidating Molecular Mechanisms: Further studies are needed to fully understand the molecular pathways through which ET exerts its neuroprotective effects. This includes investigating the role of ET in modulating neurotransmitter systems, synaptic plasticity, and neuronal survival.
Clinical Trials: Conducting clinical trials to evaluate the efficacy of ET supplementation in preventing or treating neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease.
Combination Therapies: Exploring the potential synergistic effects of ET with other neuroprotective agents or interventions to enhance therapeutic outcomes.
Metabolic and Aging Research
Long-term Effects in Animal Models: Investigating the long-term effects of ET supplementation on healthspan and lifespan in various animal models, including rodents and primates, to better understand its potential for promoting healthy aging.
Human Studies: Conducting long-term human studies to assess the impact of ET on age-related biomarkers, physical performance, and overall health in older adults.
Mechanistic Studies: Further exploring the role of ET in metabolic pathways, such as its effects on NAD+ levels and mitochondrial function, and how these changes contribute to improved healthspan and longevity.
Structural and Functional Studies
Structure-Activity Relationship (SAR): Conducting more detailed SAR studies to identify the specific structural features of ET that are essential for its biological activity. This could lead to the development of more potent analogs or derivatives.
Protein Interactions: Investigating the interactions between ET and various proteins, particularly those involved in aging and metabolic processes, to understand how ET modulates their function.
Bioavailability and Pharmacokinetics
Bioavailability Studies: Conducting studies to determine the bioavailability of ET in different tissues and organs, especially in the brain, to optimize its therapeutic use.
Pharmacokinetics: Investigating the pharmacokinetics of ET, including its absorption, distribution, metabolism, and excretion, to better understand its therapeutic potential.
Potential Therapeutic Applications
Cognitive Function: Exploring the potential of ET in improving cognitive function and preventing cognitive decline in aging populations.
Muscle Health: Investigating the effects of ET on muscle health, including muscle mass, strength, and endurance, in older adults and individuals with muscle-related disorders.
Cardiovascular Health: Studying the potential cardiovascular benefits of ET, such as its effects on blood pressure, vascular function, and lipid metabolism.
Mechanistic Insights into ET-Induced Persulfidation
Protein Targets: Identifying additional protein targets of ET-induced persulfidation and understanding how these modifications affect protein function and cellular processes.
Signal Transduction Pathways: Investigating the downstream signaling pathways activated by ET-induced persulfidation and their role in mediating ET’s beneficial effects.
Development of ET-Enriched Foods and Supplements
Biofortification: Developing food sources or dietary supplements enriched with ET to increase its intake in the general population.
Nutritional Interventions: Conducting nutritional intervention studies to assess the impact of ET-enriched diets on health outcomes in different populations.
Potential Toxicity and Safety
Toxicity Studies: Conducting comprehensive toxicity studies to ensure the safety of ET supplementation, especially in long-term use.
Dose-Response Relationships: Establishing dose-response relationships for ET to determine the optimal doses for therapeutic effects while minimizing potential risks.
Mechanistic Studies on ET and CSE Interaction
Molecular Docking and Dynamics: Using molecular docking and dynamics simulations to further understand the interaction between ET and CSE at the molecular level.
Genetic and Epigenetic Factors: Investigating the genetic and epigenetic factors that influence the expression and activity of CSE and how these factors affect the response to ET.
Potential Therapeutic Applications in Other Diseases
Metabolic Disorders: Exploring the potential of ET in the management of metabolic disorders such as diabetes, obesity, and metabolic syndrome.
Inflammatory and Immune Responses: Investigating the effects of ET on inflammatory and immune responses, and its potential use in the treatment of inflammatory diseases.
According to a report by DataM Intelligence, the ergothioneine market was valued at USD 29.6 million in 2022; it is expected to reach USD 368.2 million by 2030, with a CAGR of 38.1% during the forecast period (2024-2031).
Copyright © 2008-2026 LookChem.com All rights reserved.
